2025年12月3日监管动态
Regulatory actions for Dec. 3, 2025
生物技术与制药领域的最新动态
Regulatory actions for Dec. 3, 2025
With Phase 3 Duchenne success, Capricor plots path forward after FDA rejection
Black Diamond reports mid-stage lung cancer data, continues its hunt for a partner
Capricor soars on positive results for Duchenne cell therapy
Membrane potential mediates the cellular response to mechanical pressure
The unique architecture of umbrella toxins permits a two-tiered molecular bet-hedging strategy for interbacterial antagonism
A stepwise decoding mechanism for heat sensing in plants connects lipid remodeling to a nuclear signaling cascade
pTα enhances mRNA translation and potentiates CAR T cells for solid tumor eradication
The effect of shingles vaccination at different stages of the dementia disease course
Olympus-backed robotics startup Swan EndoSurgical taps Stryker vet for CEO
Fierce Biotech Fundraising Tracker '25: Triana glues $120M series B; Protego raises $130M
FDA approves next-gen prostate cancer PSA test from Cleveland Diagnostics
With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis
Pfizer-backed Triana scores $120M series B to take molecular glue degrader into clinic
Orion's €180M milestone payment; Iolyx partners dry eye candidate
Pfizer-allied molecular glue startup Triana collects $120M Series B
Pharvaris’ pill succeeds in late-stage trial for rare swelling disorder
From Mt. Fuji to the Lab Bench: A UW-Madison Student’s Summer in Japan
Morgan Stanley Initiates Coverage on Agilent Technologies (NYSE:A) - MarketBeat
Subcellular proteomics of the protist Paradiplonema papillatum reveals the digestive capacity of the cell membrane and the plasticity of peroxisomes across euglenozoans